Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Laryngoscope ; 134(1): 272-282, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37436167

ABSTRACT

OBJECTIVES: No curative injectable therapy exists for unilateral vocal fold paralysis. Herein, we explore the early implications of muscle-derived motor-endplate expressing cells (MEEs) for injectable vocal fold medialization after recurrent laryngeal nerve (RLN) injury. METHODS: Yucatan minipigs underwent right RLN transection (without repair) and muscle biopsies. Autologous muscle progenitor cells were isolated, cultured, differentiated, and induced to form MEEs. Three weeks after the injury, MEEs or saline were injected into the paralyzed right vocal fold. Outcomes including evoked laryngeal electromyography (LEMG), laryngeal adductor pressure, and acoustic vocalization data were analyzed up to 7 weeks post-injury. Harvested porcine larynges were examined for volume, gene expression, and histology. RESULTS: MEE injections were tolerated well, with all pigs demonstrating continued weight gain. Blinded analysis of videolaryngoscopy post-injection revealed infraglottic fullness, and no inflammatory changes. Four weeks after injection, LEMG revealed on average higher right distal RLN activity retention in MEE pigs. MEE-injected pigs on average had vocalization durations, frequencies, and intensities higher than saline pigs. Post-mortem, the MEE-injected larynges revealed statistically greater volume on quantitative 3D ultrasound, and statistically increased expression of neurotrophic factors (BDNF, NGF, NTF3, NTF4, NTN1) on quantitative PCR. CONCLUSIONS: Minimally invasive MEE injection appears to establish an early molecular and microenvironmental framework to encourage innate RLN regeneration. Longer follow-up is needed to determine if early findings will translate into functional contraction. LEVEL OF EVIDENCE: NA Laryngoscope, 134:272-282, 2024.


Subject(s)
Larynx , Recurrent Laryngeal Nerve Injuries , Vocal Cord Paralysis , Animals , Swine , Vocal Cords , Swine, Miniature , Vocal Cord Paralysis/therapy , Electromyography , Recurrent Laryngeal Nerve/surgery , Muscle Cells , Laryngeal Muscles/innervation
2.
J Cell Sci Ther ; 14(1)2023.
Article in English | MEDLINE | ID: mdl-37250272

ABSTRACT

Objective: To describe how differing injector needles and delivery vehicles impact Autologous Muscle-Derived Cell (AMDC) viability when used for laryngeal injection. Methods: In this study, adult porcine muscle tissue was harvested and used to create AMDC populations. While controlling cell concentration (1 × 107 cells/ml), AMDCs including Muscle Progenitor Cells (MPCs) or Motor Endplate Expressing Cells (MEEs) were suspended in either phosphate-buffered saline or polymerizable (in-situ scaffold forming) type I oligomeric collagen solution. Cell suspensions were then injected through 23- and 27-gauge needles of different lengths at the same rate (2 ml/min) using a syringe pump. Cell viability was measured immediately after injection and 24- and 48-hours post-injection, and then compared to baseline cell viability prior to injection. Results: The viability of cells post-injection was not impacted by needle length or needle gauge but was significantly impacted by the delivery vehicle. Overall, injection of cells using collagen as a delivery vehicle maintained the highest cell viability. Conclusion: Needle gauge, needle length, and delivery vehicle are important factors that can affect the viability of injected cell populations. These factors should be considered and adapted to improve injectable MDC therapy outcomes when used for laryngeal applications.

3.
Biomater Sci ; 11(9): 3278-3296, 2023 May 02.
Article in English | MEDLINE | ID: mdl-36942875

ABSTRACT

The efficacy and longevity of medical implants and devices is largely determined by the host immune response, which extends along a continuum from pro-inflammatory/pro-fibrotic to anti-inflammatory/pro-regenerative. Using a rat subcutaneous implantation model, along with histological and transcriptomics analyses, we characterized the tissue response to a collagen polymeric scaffold fabricated from polymerizable type I oligomeric collagen (Oligomer) in comparison to commercial synthetic and collagen-based products. In contrast to commercial biomaterials, no evidence of an immune-mediated foreign body reaction, fibrosis, or bioresorption was observed with Oligomer scaffolds for beyond 60 days. Oligomer scaffolds were noninflammatory, eliciting minimal innate inflammation and immune cell accumulation similar to sham surgical controls. Genes associated with Th2 and regulatory T cells were instead upregulated, implying a novel pathway to immune tolerance and regenerative remodeling for biomaterials.


Subject(s)
Biocompatible Materials , Tissue Scaffolds , Rats , Animals , Biocompatible Materials/pharmacology , Collagen/metabolism , Foreign-Body Reaction , Collagen Type I
4.
Nat Prod Res ; 36(5): 1143-1150, 2022 Mar.
Article in English | MEDLINE | ID: mdl-33342291

ABSTRACT

Ophiobolin A is a secondary phytotoxic metabolite produced by some pathogenic fungal species responsible for severe plant diseases, considered to play a role in disease development and symptom appearance. Herein we investigated whether the phytotoxic activities of ophiobolin A against weed species could be improved by nanoencapsulation. Given the rapid natural degradation of the compound, it was hoped that nanoencapsulation would prolong the phytotoxic effects or enhance the bioactivity, thus leading to improved weed control capabilities. This article presents an assessment of the effectiveness of encapsulated ophiobolin A on 11 commonly found weed species, compared to the pure ophiobolin, to the particle alone, and a combination of mixed particles and ophiobolin A, by applying the solution droplets to both intact or injured leaf surface, on the adaxial or abaxial side. The bioassays showed the improved efficacy of the encapsulated ophiobolin, and the need for leaf lesions to diffuse the particles into the tissues.[Formula: see text].


Subject(s)
Alkaloids , Sesterterpenes , Plant Diseases , Weed Control
5.
Am J Physiol Endocrinol Metab ; 319(2): E388-E400, 2020 08 01.
Article in English | MEDLINE | ID: mdl-32543944

ABSTRACT

Replacement of islets/ß-cells that provide long-lasting glucose-sensing and insulin-releasing functions has the potential to restore extended glycemic control in individuals with type 1 diabetes. Unfortunately, persistent challenges preclude such therapies from widespread clinical use, including cumbersome administration via portal vein infusion, significant loss of functional islet mass upon administration, limited functional longevity, and requirement for systemic immunosuppression. Previously, fibril-forming type I collagen (oligomer) was shown to support subcutaneous injection and in situ encapsulation of syngeneic islets within diabetic mice, with rapid (<24 h) reversal of hyperglycemia and maintenance of euglycemia for beyond 90 days. Here, we further evaluated this macroencapsulation strategy, defining effects of islet source (allogeneic and xenogeneic) and dose (500 and 800 islets), injection microenvironment (subcutaneous and intraperitoneal), and macrocapsule format (injectable and preformed implantable) on islet functional longevity and recipient immune response. We found that xenogeneic rat islets functioned similarly to or better than allogeneic mouse islets, with only modest improvements in longevity noted with dosage. Additionally, subcutaneous injection led to more consistent encapsulation outcomes along with improved islet health and longevity, compared with intraperitoneal administration, whereas no significant differences were observed between subcutaneous injectable and preformed implantable formats. Collectively, these results document the benefits of incorporating natural collagen for islet/ß-cell replacement therapies.


Subject(s)
Cell Encapsulation/methods , Collagen , Diabetes Mellitus, Type 1/therapy , Islets of Langerhans Transplantation/methods , Allografts , Animals , Blood Glucose/analysis , Cell Survival , Collagen/chemistry , Diabetes Mellitus, Experimental/therapy , Diabetes Mellitus, Type 1/blood , Graft Survival , Heterografts , Injections, Intraperitoneal , Injections, Subcutaneous , Insulin-Secreting Cells/physiology , Insulin-Secreting Cells/transplantation , Islets of Langerhans/physiology , Mice , Mice, Inbred C57BL , Rats , Rats, Sprague-Dawley
6.
J Geriatr Oncol ; 11(7): 1108-1114, 2020 09.
Article in English | MEDLINE | ID: mdl-32222347

ABSTRACT

OBJECTIVE: Older adults with cancer are at higher risk for costly and potentially dangerous hospital readmissions. Identifying risk factors for readmission in this population is important for future prevention of readmission. MATERIALS AND METHODS: Hospital discharges among patients ≥ 65 years with solid tumors on non-surgical services from 2006-2011 were reviewed in this matched case-control study. We abstracted patient/cancer characteristics; functional status; fall risk; chemotherapy line; comorbidities; laboratory values; discharge parameters; and miscellaneous information (Do Not Resuscitate Order, pain scores) from medical records. Conditional logistic regression was used for univariate and multivariable analysis. RESULTS: This analysis included 184 case-patients readmitted within 30 days after discharge from the index admission and 184 sex- and age-matched control-patients discharged from index admission within three months of the cases with no readmission. Cases and controls had no differences in terms of primary cancer type, treatment, and index admission reason. Cases were more likely to have abnormal hemoglobin, albumin, sodium, and SGOT on discharge. Compared to those with ≤1 abnormal laboratory test, patients with 2 or more abnormal test results were 3 times more likely to be readmitted within 30 days. CONCLUSION: This study demonstrated that older adults with cancer who had at least 2 abnormal laboratory results (hemoglobin, albumin, sodium, and SGOT) at discharge were 3 times more likely to be readmitted within 30 days compared to those with ≤1 abnormal results. These laboratory values may be predictive of the risk of readmission, and should be monitored before discharge to potentially prevent readmission.


Subject(s)
Neoplasms , Patient Readmission , Aged , Case-Control Studies , Humans , Neoplasms/therapy , Patient Discharge , Retrospective Studies , Risk Factors
8.
Appl Ergon ; 82: 102933, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31465949

ABSTRACT

There are compelling findings that open-plan office environments are associated with declines in employee wellbeing. In spite of this, the move towards shared office environments continues; yet there is a lack of research describing open-plan offices that have positive outcomes for workers. We describe a "best practice" open-plan fit-out of a law firm and provide data from occupants relating to their performance, well-being, and collegial relationships. Six months after moving to an open-plan office, staff were anonymously surveyed, and 24 were interviewed. Fourteen months later, occupants responded to a follow-up survey. Positive outcomes relating to aesthetics, collegiality, and communication were achieved through good technical design and thoughtful ergonomic assessment of the needs of employees and the requirements of their tasks. A gender difference emerged whereby female, but not male, workers in this environment reported feeling observed. This has implications for the relatively different impact these environments may have on workers. Thus, by following ergonomic principles to create open-plan offices that are 'safe by design' organizations can ameliorate many of the negative consequences associated with these environments.


Subject(s)
Built Environment/psychology , Ergonomics , Interior Design and Furnishings , Job Satisfaction , Workplace/psychology , Adult , Female , Follow-Up Studies , Humans , Longitudinal Studies , Male , Middle Aged , Retrospective Studies , Sex Factors , Work/psychology
9.
Clin Breast Cancer ; 19(2): 89-96, 2019 04.
Article in English | MEDLINE | ID: mdl-30503309

ABSTRACT

INTRODUCTION: Phase II clinical trials including geriatric assessment (GA) measures are critical for improving the evidence base for older adults with cancer. We assessed the efficacy and tolerability of nab-paclitaxel in older adults with metastatic breast cancer (MBC). PATIENTS AND METHODS: Patients aged ≥ 65 years with MBC and ≤ 1 previous line of chemotherapy received 100 mg of nab-paclitaxel on days 1, 8, and 15 of a 28-day cycle. A GA was completed pre-chemotherapy, and the validated Cancer and Aging Research Group (CARG) chemotherapy toxicity risk score was calculated. Relationships between tolerability (number of courses, hospitalizations, dose reductions, and toxicity) and risk score were assessed using general linear models, Student t tests, and the Fisher test. Response rate and progression-free survival were evaluated using the Kaplan-Meier method. RESULTS: Forty patients (mean age, 73 years; range, 65-87 years) were included. The median number of cycles was 6, 75% (n = 30) of patients had ≥ 1 dose hold, and 50% (n = 20) had ≥ 1 dose reduction. Fifty-eight percent (n = 23) had treatment-related ≥ grade 3 toxicities, and 30% (n = 12) were hospitalized owing to toxicity. Thirty-five percent (n = 14) responded, and the median progression-free survival was 6.5 months (95% confidence interval, 5.5 months to undefined). Patients with intermediate/high toxicity risk scores had higher risk of grade ≥ 3 toxicity than those with low risk scores (odds ratio, 5.8; 95% confidence interval, 1.3-33.1; P = .01). A higher mean risk score was associated with higher likelihood of dose reductions and hospitalizations. CONCLUSIONS: Among older adults with MBC receiving weekly nab-paclitaxel, more than one-half experienced ≥ grade 3 chemotherapy toxicity. However, a GA-based risk score could predict treatment tolerability.


Subject(s)
Albumins/therapeutic use , Antineoplastic Agents, Phytogenic/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Paclitaxel/therapeutic use , Aged , Aged, 80 and over , Albumins/administration & dosage , Albumins/toxicity , Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents, Phytogenic/toxicity , Drug Administration Schedule , Female , Geriatric Assessment , Humans , Male , Neoplasm Metastasis , Paclitaxel/administration & dosage , Paclitaxel/toxicity , Treatment Outcome
10.
Magn Reson Imaging ; 54: 218-224, 2018 12.
Article in English | MEDLINE | ID: mdl-30076946

ABSTRACT

As the number of older adults in the U.S. increases, so too will the incidence of cancer and cancer-related cognitive impairment (CRCI). However, the exact underlying biological mechanism for CRCI is not yet well understood. We utilized susceptibility-weighted imaging with quantitative susceptibility mapping, a non-invasive MRI-based technique, to assess longitudinal iron deposition in subcortical gray matter structures and evaluate its association with cognitive performance in women age 60+ with breast cancer receiving adjuvant chemotherapy and age-matched women without breast cancer as controls. Brain MRI scans and neurocognitive scores from the NIH Toolbox for Cognition were obtained before chemotherapy (time point 1) and within one month after the last infusion of chemotherapy for the patients and at matched intervals for the controls (time point 2). There were 14 patients age 60+ with breast cancer (mean age 66.3 ±â€¯5.3 years) and 13 controls (mean age 68.2 ±â€¯6.1 years) included in this study. Brain iron increased as age increased. There were no significant between- or within- group differences in neurocognitive scores or iron deposition at time point 1 or between time points 1 and 2 (p > 0.01). However, there was a negative correlation between iron in the globus pallidus and the fluid cognition composite scores in the control group at time point 1 (r = -0.71; p < 0.01), but not in the chemotherapy group. Baseline iron in the putamen was negatively associated with changes in the oral reading recognition scores in the control group (r = 0.74, p < 0.01), but not in the chemotherapy group. Brain iron assessment did not indicate cancer or chemotherapy related short-term differences, yet some associations with cognition were observed. Studies with larger samples and longer follow-up intervals are warranted.


Subject(s)
Brain/diagnostic imaging , Breast Neoplasms/diagnostic imaging , Chemotherapy, Adjuvant , Iron/metabolism , Aged , Aged, 80 and over , Brain Stem/diagnostic imaging , Breast Neoplasms/drug therapy , Cognition , Cognitive Dysfunction/diagnostic imaging , Cognitive Dysfunction/etiology , Female , Globus Pallidus/diagnostic imaging , Humans , Magnetic Resonance Imaging , Middle Aged , Neuroimaging , Neuropsychological Tests , Pilot Projects , Putamen/diagnostic imaging
11.
Breast Cancer Res ; 20(1): 38, 2018 05 02.
Article in English | MEDLINE | ID: mdl-29720224

ABSTRACT

BACKGROUND: Cognitive decline is among the most feared treatment-related outcomes of older adults with cancer. The majority of older patients with breast cancer self-report cognitive problems during and after chemotherapy. Prior neuroimaging research has been performed mostly in younger patients with cancer. The purpose of this study was to evaluate longitudinal changes in brain volumes and cognition in older women with breast cancer receiving adjuvant chemotherapy. METHODS: Women aged ≥ 60 years with stage I-III breast cancer receiving adjuvant chemotherapy and age-matched and sex-matched healthy controls were enrolled. All participants underwent neuropsychological testing with the US National Institutes of Health (NIH) Toolbox for Cognition and brain magnetic resonance imaging (MRI) prior to chemotherapy, and again around one month after the last infusion of chemotherapy. Brain volumes were measured using Neuroreader™ software. Longitudinal changes in brain volumes and neuropsychological scores were analyzed utilizing linear mixed models. RESULTS: A total of 16 patients with breast cancer (mean age 67.0, SD 5.39 years) and 14 age-matched and sex-matched healthy controls (mean age 67.8, SD 5.24 years) were included: 7 patients received docetaxel and cyclophosphamide (TC) and 9 received chemotherapy regimens other than TC (non-TC). There were no significant differences in segmented brain volumes between the healthy control group and the chemotherapy group pre-chemotherapy (p > 0.05). Exploratory hypothesis generating analyses focusing on the effect of the chemotherapy regimen demonstrated that the TC group had greater volume reduction in the temporal lobe (change = - 0.26) compared to the non-TC group (change = 0.04, p for interaction = 0.02) and healthy controls (change = 0.08, p for interaction = 0.004). Similarly, the TC group had a decrease in oral reading recognition scores (change = - 6.94) compared to the non-TC group (change = - 1.21, p for interaction = 0.07) and healthy controls (change = 0.09, p for interaction = 0.02). CONCLUSIONS: There were no significant differences in segmented brain volumes between the healthy control group and the chemotherapy group; however, exploratory analyses demonstrated a reduction in both temporal lobe volume and oral reading recognition scores among patients on the TC regimen. These results suggest that different chemotherapy regimens may have differential effects on brain volume and cognition. Future, larger studies focusing on older adults with cancer on different treatment regimens are needed to confirm these findings. TRIAL REGISTRATION: ClinicalTrials.gov, NCT01992432 . Registered on 25 November 2013. Retrospectively registered.


Subject(s)
Brain/diagnostic imaging , Breast Neoplasms/drug therapy , Chemotherapy, Adjuvant/adverse effects , Cognition/drug effects , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Brain/drug effects , Brain/physiopathology , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/physiopathology , Female , Humans , Magnetic Resonance Imaging , Neuropsychological Tests , Pilot Projects , Treatment Outcome
12.
J Biomech Eng ; 140(8)2018 08 01.
Article in English | MEDLINE | ID: mdl-29570754

ABSTRACT

Recent applications of computational fluid dynamics (CFD) applied to the cardiovascular system have demonstrated its power in investigating the impact of hemodynamics on disease initiation, progression, and treatment outcomes. Flow metrics such as pressure distributions, wall shear stresses (WSS), and blood velocity profiles can be quantified to provide insight into observed pathologies, assist with surgical planning, or even predict disease progression. While numerous studies have performed simulations on clinical human patient data, it often lacks prediagnosis information and can be subject to large intersubject variability, limiting the generalizability of findings. Thus, animal models are often used to identify and manipulate specific factors contributing to vascular disease because they provide a more controlled environment. In this review, we explore the use of CFD in animal models in recent studies to investigate the initiating mechanisms, progression, and intervention effects of various vascular diseases. The first section provides a brief overview of the CFD theory and tools that are commonly used to study blood flow. The following sections are separated by anatomical region, with the abdominal, thoracic, and cerebral areas specifically highlighted. We discuss the associated benefits and obstacles to performing CFD modeling in each location. Finally, we highlight animal CFD studies focusing on common surgical treatments, including arteriovenous fistulas (AVF) and pulmonary artery grafts. The studies included in this review demonstrate the value of combining CFD with animal imaging and should encourage further research to optimize and expand upon these techniques for the study of vascular disease.


Subject(s)
Computer Simulation , Hydrodynamics , Vascular Diseases/physiopathology , Animals , Disease Models, Animal , Hemodynamics
13.
PLoS One ; 13(1): e0189813, 2018.
Article in English | MEDLINE | ID: mdl-29320499

ABSTRACT

Mirror-self recognition (MSR) is a behavioral indicator of self-awareness in young children and only a few other species, including the great apes, dolphins, elephants and magpies. The emergence of self-awareness in children typically occurs during the second year and has been correlated with sensorimotor development and growing social and self-awareness. Comparative studies of MSR in chimpanzees report that the onset of this ability occurs between 2 years 4 months and 3 years 9 months of age. Studies of wild and captive bottlenose dolphins (Tursiops truncatus) have reported precocious sensorimotor and social awareness during the first weeks of life, but no comparative MSR research has been conducted with this species. We exposed two young bottlenose dolphins to an underwater mirror and analyzed video recordings of their behavioral responses over a 3-year period. Here we report that both dolphins exhibited MSR, indicated by self-directed behavior at the mirror, at ages earlier than generally reported for children and at ages much earlier than reported for chimpanzees. The early onset of MSR in young dolphins occurs in parallel with their advanced sensorimotor development, complex and reciprocal social interactions, and growing social awareness. Both dolphins passed subsequent mark tests at ages comparable with children. Thus, our findings indicate that dolphins exhibit self-awareness at a mirror at a younger age than previously reported for children or other species tested.


Subject(s)
Awareness , Bottle-Nosed Dolphin/physiology , Animals
14.
Toxicol Mech Methods ; 28(6): 410-414, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29338525

ABSTRACT

Pyocyanin (PCN) is a virulence factor secreted by Pseudomonas aeruginosa (P. aeruginosa) that has been shown to have numerous toxic effects in both in vitro and in vivo studies. Such toxicities include pro-inflammatory and pro-oxidant mediated responses. It is hypothesized that PCN can cross biological membranes and reach the systemic circulation, but no previous studies have investigated this. The aim of this study was, therefore, to quantify PCN in plasma and assess if systemic responses were occurring after localized intranasal administration in C57BL/6 J mice. This was achieved through the plasma quantification of PCN and assessment of changes to behavior using two commonly used tests, the forced swimming test and the open field test. Furthermore, evidence of systemic oxidative stress and inflammation was measured using malondialdehyde (MDA) and TNF-α post PCN exposure. PCN was found to cross into systemic circulation but in a variable manner. Furthermore, significant increases in plasma TNF-α and MDA (both p < 0.001) were observed along with changes in behavior indicative of systemic inflammatory responses.


Subject(s)
Behavior, Animal/drug effects , Malondialdehyde/blood , Oxidative Stress/drug effects , Pyocyanine/toxicity , Tumor Necrosis Factor-alpha/blood , Virulence Factors/toxicity , Administration, Intranasal , Animals , Inflammation , Male , Mice, Inbred C57BL , Motor Activity/drug effects , Pseudomonas aeruginosa/pathogenicity , Pyocyanine/blood , Swimming , Virulence Factors/blood
15.
Int J Nanomedicine ; 12: 3851-3863, 2017.
Article in English | MEDLINE | ID: mdl-28572729

ABSTRACT

The aim of this study was to develop a manufacturing protocol for large-scale production of doped titania radiosensitizing nanoparticles (NPs) to establish their activity under hypoxia and to produce a multimodal radiosensitizing embolic particle for cancer treatment. We have previously shown that radiosensitizing NPs can be synthesized from titania doped with rare earth elements, especially gadolinium. To translate this technology to the clinic, a crucial step is to find a suitable, scalable, high-throughput method. Herein, we have described the use of flame spray pyrolysis (FSP) to generate NPs from titanium and gadolinium precursors to produce titania NPs doped with 5 at% gadolinium. The NPs were fully characterized, and their capacity to act as radiosensitizers was confirmed by clonogenic assays. The integrity of the NPs in vitro was also ascertained due to the potentially adverse effects of free gadolinium in the body. The activity of the NPs was then studied under hypoxia since this is often a barrier to effective radiotherapy. In vitro radiosensitization experiments were performed with both the hypoxia mimetics deferoxamine and cobalt chloride and also under true hypoxia (oxygen concentration of 0.2%). It was shown that the radiosensitizing NPs were able to cause a significant increase in cell death even after irradiation under hypoxic conditions such as those found in tumors. Subsequently, the synthesized NPs were used to modify polystyrene embolization microparticles. The NPs were sintered to the surface of the microparticles by heating at 230°C for 15 minutes. This resulted in a good coverage of the surface and to generate embolization particles that were shown to be radiosensitizing. Such multimodal particles could therefore result in occlusion of the tumor blood vessels in conjunction with localized reactive oxygen species generation, even under hypoxic conditions such as those found in the center of tumors.


Subject(s)
Embolization, Therapeutic/instrumentation , Nanoparticles/chemistry , Neoplasms/therapy , Radiation-Sensitizing Agents/pharmacology , Titanium/chemistry , Cell Line, Tumor , Cobalt/chemistry , Cobalt/pharmacology , Deferoxamine/pharmacology , Embolization, Therapeutic/methods , Gadolinium/chemistry , Humans , Nanoparticles/therapeutic use , Neoplasms/radiotherapy , Radiation-Sensitizing Agents/chemistry , Tumor Hypoxia
16.
Appl Ergon ; 60: 103-115, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28166868

ABSTRACT

The prevalence of flexible and shared office spaces is increasing significantly, yet the socioemotional outcomes associated with these environments are under researched. Utilising the job demands-resources (JD-R) model we investigate both the demands and the resources that can accrue to workers as a result of shared work environments and hot-desking. Data were collected from work experienced respondents (n = 1000) assessing the extent to which they shared their office space with others, along with demands comprising distractions, uncooperative behaviours, distrust, and negative relationships, and resources from co-worker friendships and supervisor support. We found that, as work environments became more shared (with hot-desking being at the extreme end of the continuum), not only were there increases in demands, but co-worker friendships were not improved and perceptions of supervisory support decreased. Findings are discussed in relation to employee well-being and recommendations are made regarding how best to ameliorate negative consequences of shared work environments.


Subject(s)
Interior Design and Furnishings , Spatial Behavior , Workplace/organization & administration , Workplace/psychology , Adult , Cooperative Behavior , Emotions , Employment , Female , Humans , Interpersonal Relations , Male , Middle Aged , Models, Psychological , Social Behavior , Social Support , Trust
17.
Int J Oncol ; 50(3): 773-786, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28112374

ABSTRACT

Herein we have undertaken a systematic analysis of the effects of the fungal derivative ophiobolin A (OphA) on eight cancer cell lines from different tissue types. The LD50 for each cell line was determined and the change in cell size determined. Flow cytometric analysis and western blotting were used to assess the cell death markers for early apoptosis, late apoptosis and necrosis, and the involvement of the caspase signalling pathway. Alterations in calcium levels and reactive oxygen species were assessed due to their integral involvement in intracellular signalling. Subsequently, the endoplasmic reticulum (ER) and mitochondrial responses were investigated more closely. The extent of ER swelling, and the upregulation of proteins involved in the unfolded protein responses (UPR) were seen to vary according to cell line. The mitochondria were also shown to behave differently in response to the OphA in the different cell lines in terms of the change in membrane potential, the total area of mitochondria in the cell and the number of mitochondrial bifurcations. The data obtained in the present study indicate that the cancer cell lines tested are unable to successfully activate the ER stress/UPR responses, and that the mitochondria appear to be a central player in OphA-induced cancer cell death.


Subject(s)
Apoptosis/drug effects , Endoplasmic Reticulum Stress/drug effects , Membrane Potential, Mitochondrial/drug effects , Mycotoxins/therapeutic use , Sesterterpenes/therapeutic use , Calcium/metabolism , Caspases/metabolism , Cell Line, Tumor , Endoplasmic Reticulum/drug effects , Flow Cytometry , HeLa Cells , Humans , MCF-7 Cells , Mitochondria/drug effects , Mitochondria/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , Unfolded Protein Response/drug effects
18.
J Mater Sci Mater Med ; 26(8): 218, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26223792

ABSTRACT

Radiopaque and fluorescent embolic particles have been synthesized and characterised to match the size of vasculature found in tumours to ensure effective occlusion of the vessels. A literature search showed that the majority of vessels surrounding a tumour were less than 50 µm and therefore polydispersed polystyrene particles with a peak size of 50 µm have been synthesised. The embolic particles contain 5-8 nm amorphous tantalum oxide nanoparticles which provide X-ray contrast. Embolic particles containing up to 9.4 wt% tantalum oxide were prepared and showed significant contrast compared to the undoped polystyrene particles. The X-ray contrast of the embolic particles was shown to be linear (R(2) = 0.9) with respect to the concentration of incorporated tantalum nanoparticles. A model was developed which showed that seventy-five 50 µm embolic particles containing 10% tantalum oxide could provide the same contrast as 5 cm of bone. Therefore, the synthesized particles would provide sufficient X-ray contrast to enable visualisation within a tumour.


Subject(s)
Embolization, Therapeutic/methods , Contrast Media/chemistry , Contrast Media/therapeutic use , Humans , Materials Testing , Metal Nanoparticles/chemistry , Metal Nanoparticles/therapeutic use , Metal Nanoparticles/ultrastructure , Microscopy, Electron, Transmission , Neoplasms/blood supply , Neoplasms/diagnostic imaging , Neoplasms/therapy , Oxides/chemistry , Oxides/therapeutic use , Particle Size , Polystyrenes/chemistry , Tantalum/chemistry , Tantalum/therapeutic use , Tomography, X-Ray Computed
19.
Pharm Res ; 31(10): 2904-17, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24792832

ABSTRACT

PURPOSE: To design and synthesize chemoembolization particles for the delivery of Ophiobolin A (OphA), a promising fungal-derived chemotherapeutic, directly at the tumour location. To investigate cell death mechanism of OphA on a Rhabdomyosarcoma cancer (RD) cell line. Rhabdomyosarcoma is the most common soft tissue sarcoma in children; with a 5-year survival rate of between 30 and 65%. METHODS: Multimodal chemoembolization particles were prepared by sintering mesoporous silica nanoparticles, prepared by the sol-gel method, onto the surface of polystyrene microspheres, prepared by suspension copolymerisation. The chemoembolization particles were subsequently loaded with OphA. The effects of OphA in vitro were characterised by flow cytometry and nanoparticle tracking analysis (NanoSight). RESULTS: High loading of OphA onto the chemoembolization particles was achieved. The subsequent release of OphA onto RD cells in culture showed a 70% reduction in cell viability. OphA caused RD cells to round up and their membrane to bleb and caused cell death via apoptosis. OphA caused both an increase in the number of microvesicles produced and an increase in DNA content within these microvesicles. CONCLUSIONS: The prepared chemoembolization particles showed good efficacy against RD cells in culture.


Subject(s)
Antineoplastic Agents, Phytogenic/administration & dosage , Chemoembolization, Therapeutic , Drug Carriers/chemistry , Nanoparticles/chemistry , Sesterterpenes/administration & dosage , Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Drug Liberation , Flow Cytometry , Humans , Microscopy, Electron, Transmission , Particle Size , Polystyrenes/chemistry , Rhabdomyosarcoma, Embryonal/blood supply , Rhabdomyosarcoma, Embryonal/pathology , Sesterterpenes/pharmacology , Silicon Dioxide/chemistry , Surface Properties
20.
J Appl Psychol ; 99(4): 651-64, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24377392

ABSTRACT

Drawing on various theoretical perspectives, extant research has primarily treated subordinate organizational deviance as a consequence of abusive supervision. Yet, social interaction theories of aggression and victimization perspectives provide support for the opposite ordering, suggesting that subordinate organizational deviance may be an antecedent of abusive supervision. By using a cross-lagged panel design, we empirically test the potentially reciprocal relation between abusive supervision and subordinate organizational deviance. In Study 1, we measured both abusive supervision and organizational deviance at 2 separate times with a 20-month lag between measurement occasions and found evidence that subordinate organizational deviance leads to abusive supervision, but not vice versa. In Study 2, with a shorter time lag (i.e., 6 months), the reciprocal effects of abusive supervision and organizational deviance were supported. Furthermore, we found that the effects of abusive supervision on organizational deviance were moderated by subordinate self-control capacity and intention to quit such that the effects were only significant when subordinates had low self-control capacity and high intention to quit. Theoretical and practical implications are discussed.


Subject(s)
Employment/psychology , Interprofessional Relations , Personnel Management , Adult , Female , Humans , Male , Organizational Culture
SELECTION OF CITATIONS
SEARCH DETAIL
...